Abstract
Brain tumors are a group of neoplasms that arise from the constituent cells of the brain (primary tumors) or from systemic tumors that have spread to the brain (brain metastasis). They account for approximately 2% of all cancers. Combined with other CNS tumors, they are the most lethal cause of cancer in children. In people older than 40 years, brain and CNS tumors have a mortality of 8.89 per 100,000. The WHO classification divides brain tumors into 17 groups and more than 100 subtypes using histological and genetic features. Brain tumors may cause clinical manifestations due the local mass effect, perilesional edema, brain invasion, and increased intracranial pressure. A thorough medical history, neurological examination, and diagnostic neuroimaging are fundamental for the proper patient work-up. Surgery is performed in almost all cases when patient has a clinical stable condition and is usually followed by chemo-, radio-, and more recently immunotherapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Readings and References
Anderson SW, Damasio H, Damasio AR. A neural basis for collecting behaviour in humans. Brain. 2005;128(Pt 1):201–12. Epub 2004 Nov 17
Bell BA, Smith MA, Kean DM, McGhee CN, MacDonald HL, Miller JD, Barnett GH, Tocher JL, Douglas RH, Best JJ. Brain water measured by magnetic resonance imaging. Correlation with direct estimation and changes after mannitol and dexamethasone. Lancet. 1987;1(8524):66–9.
Berleur MP, Cordier S. The role of chemical, physical, or viral exposures and health factors in neurocarcinogenesis: implications for epidemiologic studies of brain tumors. Cancer Causes Control. 1995;6(3):240–56.
Bernstein M, Berger MS. Neuro-oncology. The essentials. 2nd ed. New York: Thieme Medical Publishers, Inc; 2008.
Coble JB, Dosemeci M, Stewart PA, et al. Occupational exposure to magnetic fields and the risk of brain tumors. NeuroOncol. 2009;11(3):242–9. https://doi.org/10.1215/15228517-2009-002.
Forsyth PA, Posner JB. Headaches in patients with brain tumors: a study of 111 patients. Neurology. 1993 Sep;43(9):1678–83.
French LA, Galicich JH. The use of steroids for control of cerebral edema. Clin Neurosurg. 1964;10:212–23.
Goffaux P, Fortin D. Brain tumor headaches: from bedside to bench. Neurosurgery. 2010;67(2):459–66. https://doi.org/10.1227/01.NEU.0000372092.96124.E6.
Jacobs AH, Kracht LW, Gossmann A, Rüger MA, Thomas AV, Thiel A, Herholz K. Imaging in neurooncology. NeuroRx. 2005;2(2):333–47. Review
Keane JR. Neurologic symptoms mistaken for gastrointestinal disease. Neurology. 1998;50:1189.
Kong X, Guan J, Yang Y, Li Y, Ma W, Wang R. A meta-analysis: do prophylactic antiepileptic drugs in patients with brain tumors decrease the incidence of seizures? Clin Neurol Neurosurg. 2015;134:98–103. https://doi.org/10.1016/j.clineuro.2015.04.010. Epub 2015 Apr 18
Little MP, Rajaraman P, Curtis RE, et al. Mobile phone use and glioma risk: comparison of epidemiological study results with incidence trends in the United States. BMJ. 2012;344:e1147.
Loghin M, Levin VA. Headache related to brain tumors. Curr Treat Options Neurol. 2006;8(1):21–32.
Lote K, Stenwig AE, Skullerud K, Hirschberg H. Prevalence and prognostic significance of epilepsy in patients with gliomas. Eur J Cancer. 1998;34(1):98–102.
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO classification of tumours of the central nervous system. 4th ed. Revised, Vol. 1. Lyon: IARC; 2016.
M K, Vecht CJ. Seizure characteristics and prognostic factors of gliomas. Epilepsia. 2013;54 Suppl 9:12–7. https://doi.org/10.1111/epi.12437.
Mahaley MS Jr, Mettlin C, Natarajan N, Laws ER Jr, Peace BB. National survey of patterns of care for brain-tumor patients. J Neurosurg. 1989;71(6):826–36.
Miller JD, Leech P. Effects of mannitol and steroid therapy on intracranial volume-pressure relationships in patients. J Neurosurg. 1975;42(3):274–81.
Moots PL, Maciunas RJ, Eisert DR, Parker RA, Laporte K, Abou-Khalil B. The course of seizure disorders in patients with malignant gliomas. Arch Neurol. 1995;52(7):717–24.
Ostrom QT, Gittleman H, Farah P, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006–2010. Neuro-Oncology. 2013;15(Suppl 2):ii1–ii56. https://doi.org/10.1093/neuonc/not151.
Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population--a prevalence study. J Clin Epidemiol. 1991;44(11):1147–57.
Ryken TC, McDermott M, Robinson PD, Ammirati M, Andrews DW, Asher AL, Burri SH, Cobbs CS, Gaspar LE, Kondziolka D, Linskey ME, Loeffler JS, Mehta MP, Mikkelsen T, Olson JJ, Paleologos NA, Patchell RA, Kalkanis SN. The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline. J Neuro-Oncol. 2010;96(1):103–14. https://doi.org/10.1007/s11060-009-0057-4. Epub 2009 Dec 3. Review.
Tucha O, Smely C, Preier M, Lange KW. Cognitive deficits before treatment among patients with brain tumors. Neurosurgery. 2000;47(2):324–33; discussion 333-4
Vázquez-Barquero A, Ibáñez FJ, Herrera S, Izquierdo JM, Berciano J, Pascual J. Isolated headache as the presenting clinical manifestation of intracranial tumors: a prospective study. Cephalalgia. 1994;14(4):270–2.
Vecht CJ, van Breemen M. Optimizing therapy of seizures in patients with brain tumors. Neurology. 2006;67(12 Suppl 4):S10–3.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
de Vasconcelos, V.L., Valadares, M.G.C., Tedeschi, H. (2019). Brain Tumors in Adults. In: Joaquim, A., Ghizoni, E., Tedeschi, H., Ferreira, M. (eds) Fundamentals of Neurosurgery. Springer, Cham. https://doi.org/10.1007/978-3-030-17649-5_17
Download citation
DOI: https://doi.org/10.1007/978-3-030-17649-5_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-17648-8
Online ISBN: 978-3-030-17649-5
eBook Packages: MedicineMedicine (R0)